Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

AstraZeneca image

AstraZeneca pulls depression drug, takes $50m hit

March 20, 2012 Research and Development, Sales and Marketing AstraZeneca, R&D, depression, failure, pipeline

AstraZeneca and partner Targacept will not file their depression drug TC-5214 for regulatory review. The decision comes after disappointing Phase …
News

AstraZeneca touting for business at partnering conference

March 19, 2012 Research and Development, Sales and Marketing AstraZeneca, Bio-Europe, R&D, partnering

AstraZeneca is marketing itself as a key partner for drug development deals, ahead of a European partnering conference.  The Bio-Europe …
News
Novartis HQ

Novartis signs experimental eye drug deal

March 19, 2012 Research and Development, Sales and Marketing Novartis, ThromboGenics, vitreomacular adhesion

Novartis will develop an experimental eye drug with ThromboGenics in a pact worth nearly $500 million.  The deal has been …
News
meeting image

Meetings, bloody meetings

March 16, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Meetings, clinical trials

I read recently that less than 2% of NHS Trust board meeting agenda items require decisions. What happens during the …
Feature

Updated set of mandatory Article 57(2) requirements for marketing authorisation holders

March 15, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV

An updated set of mandatory requirements for Marketing Authorisation Holders (MAH) to comply with Article 57(2) of the forthcoming new …
News
Press release

Photodynamic treatment for HPV shows potential

March 15, 2012 Research and Development Cancer, GE Healthcare, HPV, Photocure, ipsen, oncologly

A new photodynamic therapy treatment for human papilloma virus (HPV) associated diseases of the cervix has shown potential in a …
News

Cmed release Global Strategic and Regulatory Consulting Booklet

March 14, 2012 Research and Development

The regulatory environments within the industry continue to change and vary internationally. Cmed’s regulatory and medical professionals keep track of …
Feature
Press release
White paper

Europe’s pharma sector : living through the crisis

March 14, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Greece, Tonarelli, Witty, austerity, pharma

Pharmaceutical markets across Europe have been badly hit by the economic crisis, with revenues in some countries being decimated by …
Feature
Pfizer picture

Pfizer pulls out of $350 million insulin pact

March 14, 2012 Research and Development, Sales and Marketing Biocon, Humalog, Lantus, NovoLog, Pfizer

Pfizer has walked away from a research deal with India’s biggest biotech firm Biocon. Both companies were working on a …
News
Merck image

Merck warned over missing Januvia safety study

March 13, 2012 Research and Development FDA, Januvia, Merck, study

Merck has been warned by the FDA that it must carry out a post-marketing safety study on diabetes treatments Januvia …
News

Catalent continues investment in Global Clinical Supply services with German warehousing & controlled substance expansion

March 13, 2012 Research and Development

Somerset, NJ – March 7, 2012 — Catalent Pharma Solutions announced the completion of extended warehousing facilities in Schorndorf, Germany …
News
Press release

Catalent Expert Presents on Protein Expression in CHO Cells: Comparison of GPEx® Technology to Traditional Cell Line Engineering at Cell Culture World Congress 2012

March 13, 2012 Research and Development

Somerset, NJ February 21, 2012 — Michael Jenkins, Ph.D., General Manager of Catalent Pharma Solutions’ Middleton, WI facility, will present …
News
Press release
john_brown

Dr John Brown joins BioCity Nottingham’s board

March 13, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BioCity Nottingham, BioCity Scotland, John Brown

Dr John Brown has been appointed as a non-executive director to the board of BioCity Nottingham Ltd, which runs one …
Appointment

GSK expands apprenticeship programme

March 13, 2012 Manufacturing and Production, Research and Development GSK, Hayes, R&D, manufacturing

GlaxoSmithKline has expanded its apprenticeship programme with the creation of positions spanning manufacturing, IT, and R&D.  The multi-disciplinary scheme is …
News
Zytiga image

Strong Zytiga study results could increase uptake

March 12, 2012 Research and Development, Sales and Marketing IDMC, Janssen, Provenge, Zytiga, prostate

Janssen’s prostate cancer pill Zytiga could be on course to target a larger number of patients following a positive late-stage …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026